Preprocedural and periprocedural characteristics
| No NRI | NRI | NDR | P value | |
| Preprocedural medications | ||||
| Thrombolysis | 1361 (3.8) | 73 (6.4) | 13 (5.8) | <0.001 |
| Oral anticoagulation | 2151 (6.0) | 101 (8.9) | 12 (5.4) | <0.001 |
| No antiplatelet | 1270 (3.6) | 39 (3.4) | 17 (7.6) | 0.006 |
| Aspirin | 32 458 (91.4) | 1052 (93.3) | 198 (90.0) | 0.066 |
| Thienopyridine | 13 870 (39.0) | 329 (29.0) | 66 (29.3) | <0.001 |
| Ticagrelor | 15 234 (42.8) | 593 (52.3) | 92 (40.9) | <0.001 |
| Procedural details | ||||
| Access site | ||||
| Radial/brachial | 20 549 (57.7) | 499 (44.0) | 58 (25.8) | <0.001 |
| Femoral | 15 062 (42.3) | 635 (56.0) | 167 (74.2) | |
| Adjunctive device required | 3838 (10.8) | 176 (15.5) | 32 (14.2) | <0.001 |
| Intravascular USS | 491 (1.4) | 21 (1.9) | 6 (2.7) | 0.111 |
| Optical coherence tomography | 216 (0.6) | 9 (0.8) | 0 (0.0) | 0.364 |
| Thrombus aspiration device | 1630 (4.6) | 109 (9.6) | 22 (9.8) | <0.001 |
| Distal or proximal protection device | 59 (0.2) | 4 (0.4) | 0 (0.0) | 0.266 |
| Rotational atherectomy | 403 (1.1) | 13 (1.2) | 2 (0.9) | 0.942 |
| Fractional flow reserve | 1003 (2.8) | 16 (1.4) | 1 (0.4) | 0.002 |
| Coronary vessel | ||||
| RCA | 11 240 (31.6) | 306 (27.0) | 52 (23.1) | <0.001 |
| LAD | 14 523 (40.8) | 478 (42.2) | 99 44.0) | |
| LCx | 8566 (24.1) | 239 (21.1) | 55 24.4) | |
| Left main | 651 (1.8) | 68 (6.0) | 13 (5.8) | |
| Graft | 631 (1.8) | 43 (3.8) | 6 (2.7) | |
| Lesion type | ||||
| Lesion A or B1 | 15 210 (42.7) | 392 (34.6) | 58 (25.8) | <0.001 |
| Lesion B2 or C | 20 401 (57.3) | 742 (65.4) | 167 (74.2) | |
Values are expressed as n (%).
LAD, left anterior descending; LCx, left circumflex; NDR, new dialysis requirement; NRI, new renal impairment; RCA, right coronary artery; USS, ultrasound scan.